HomeBusinessPraxis Precision Medicines reports Phase 2/3 study results for vormatrigine in epilepsy Praxis Precision Medicines reports Phase 2/3 study results for vormatrigine in epilepsy June 1, 2026byadmin Praxis Precision Medicines reports Phase 2/3 study results for vormatrigine in epilepsy Source link
Maersk vessel exits Strait of Hormuz under US military escort Maersk vessel exits Strait of Hormuz under US military escort Source link
Shell reports $23.8 billion in government payments for 2025 Shell reports $23.8 billion in government payments for 2025 Source link
Albion No.8 lists £383m mortgage backed notes on LSE Albion No.8 lists £383m mortgage backed notes on LSE Source link